Kantonsspital St.Gallen
login

Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3

Hope S Rugo, Jens Huober, José A García-Sáenz, Norikazu Masuda, Joo Hyuk Sohn, Valerie A M Andre, Susana Barriga, Joanne Cox & Matthew Goetz

citation Rugo H S, Huober J, García-Sáenz J A, Masuda N, Sohn J H, Andre V A M, Barriga S, Cox J, Goetz M. Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3. Oncologist 2021; 26:e522.
   
type journal paper/review (English)
date of publishing 3-2021
journal title Oncologist (26/3)
ISSN electronic 1549-490X
pages e522
PubMed 33660385
DOI 10.1002/onco.13691